Fact Based List:
Deborah L. Feinstein: Four design features of ACOs that raise red flags for antitrust agencies
Submitted by Charlene Ice on Fri, 07/25/2014 - 16:30
- preventing payers from steering patients to certain providers
- tying sales of the ACO’s services to the private payer’s purchase of other services from providers outside the ACO
- requiring exclusivity that discourages providers from contracting with payers outside the ACO
- restricting a payer’s ability to make available to enrollees information on cost, quality, efficiency, and performance
Notes: Deborah L. Feinstein is the Director of the Federal Trade Commission's Bureau of Competition. This list is from her presentation at the Fifth National ACO Summit.
Source: "Antitrust Enforcement in Health Care: Proscription, not Prescription," Fifth National Accountable Care Organization Summit – Washington, DC
Source URL: http://www.ftc.gov/system/files/documents/public_statements/...
List Ratings: |
Lists You Might Also Be Interested In
- AJMC: Reported Expenses of AIM ACOs By Type of Care Input, 2016 through 2018
- Vera Gruessner: Three ways that ACOs could ensure greater cost savings for the long-term
- 6 Proposed Quality Measures in CMS' New APM Performance Pathways (APP) Model for ACOs or other APMs
- Comparison of 5 Metrics for ACOs Composed of High versus Low Minority Populations
- Roji Health Intelligence: 3 APP Reporting Measures ACOs can Target to Initiate Improvements
Login or register to post comments